Primary Hormone Receptor Negative Breast Cancer in Premenopausal Women
1 clinical trials · Condition
◉ Watch Primary Hormone Receptor Negative Breast Cancer in Premenopausal Women
| Record | Firm | Date |
|---|---|---|
| A Study of Zoledronic Acid in the Prevention of Cancer Therapy-induced Bone Loss (NCT00333229) | Novartis Pharmaceuticals | 2006-03-01 |
Track Primary Hormone Receptor Negative Breast Cancer in Premenopausal Women automatically
Every clearance here is in the API, with alerts when new ones post.